510(k) device
MeRT System
Wave Neuroscience · Transcranial Magnetic Stimulation System For Post Traumatic Stress Disorder (Ptsd) (SIG, Class II) · First FDA decision Jun 3, 2026, newest Jun 3, 2026OCD, PTSD and other psychiatric conditions
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
5
Naming "MeRT"
MAUDE reports
1
Brand "MeRT", since 2015
PubMed studies
240
Mentioning "MeRT"
AI summary across all sources
Written by Claude (Anthropic's AI) from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- MeRT SystemBreakthrough510(k)
K260402 · Decided Jun 3, 2026 · 117 days after receipt
Device type: Transcranial Magnetic Stimulation System For Post Traumatic Stress Disorder (Ptsd) (SIG) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive DisorderLocal determinationIn effectL34522First Coast Service Options, Inc.Updated Oct 21, 2022
- Transcranial Magnetic Stimulation (TMS) in the Treatment of Adults with Major Depressive DisorderLocal determinationIn effectL34998Novitas Solutions, Inc.Updated Oct 21, 2022
- Transcranial Magnetic StimulationLocal determinationIn effectL33398Wellpoint FederalUpdated Jul 16, 2026
- Transcranial Magnetic StimulationProposed local determinationProposedDL33398National Government Services, Inc.Updated Mar 27, 2026
- Transcranial Magnetic Stimulation (TMS)Local determinationIn effectL34641WPS Insurance CorporationUpdated Mar 20, 2026
- Transcranial Magnetic Stimulation (TMS)Local determinationIn effectL37086Noridian Healthcare Solutions, LLCUpdated Aug 6, 2025
- Repetitive Transcranial Magnetic Stimulation (rTMS) in AdultsLocal determinationIn effectL34869Palmetto GBAUpdated Jan 7, 2025
- Transcranial Magnetic Stimulation (TMS)Local determinationIn effectL36469CGS Administrators, LLCUpdated May 30, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "MeRT", any status and sponsor, newest update first.
- Trifecta Research StudyActive, not recruiting
Axial Therapeutic ResearchNot on our public-company list
NCT07717866 · 52 participants · Start Aug 1, 2022 · Primary completion Feb 1, 2026
Device: Magnetic e-Resonance Therapy (MeRT) · For: PTSD - Post Traumatic Stress Disorder; Cognitive Dysfunction; Brain Injury and 2 more
Sites: Northridge, California
- Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress DisorderPivotal-lookingCompleted
Wave NeuroscienceNot on our public-company list
NCT02990793 · 158 participants · Start Apr 4, 2022 · Primary completion Sep 18, 2025
Device: Active MeRT Treatment; Sham MeRT Treatment · For: PostTraumatic Stress Disorder; Traumatic Brain Injury; Postconcussive Symptoms
Sites: Costa Mesa, California; Long Beach, California; San Diego, California · 8 sites in all
Wave NeuroscienceNot on our public-company list
NCT02268084 · 96 participants · Start Oct 2014 · Primary completion Oct 2016
Device: Magnetic EEG/ECG-guided Resonance Therapy; Sham · For: Stress Disorders, Post-Traumatic
Sites: San Diego, California
72nd Medical Group, Tinker Air Force BaseFederal agency
NCT02824445 · 13 participants · Start May 2015 · Primary completion May 28, 2018
Device: individualized Transcranial Magnetic Stimulation · For: Post-Traumatic Stress Disorders
Sites: Oklahoma City, Oklahoma
Wave NeuroscienceNot on our public-company list
NCT03066505 · 31 participants · Start Feb 23, 2016 · Primary completion Apr 17, 2019
Device: Active MeRT Treatment; Sham MeRT Treatment · For: ADHD
Sites: Los Angeles, California
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "MeRT", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code SIG
1 reports: 0 malfunction, 1 injury, 0 death
Newest reports for this brand
MW5112560 · Received Oct 11, 2022 · Event dated May 1, 2022
Device type: Transcranial Magnetic Stimulator (OBP)
Device problem as coded: Patient-Device Incompatibility
Patient problem as coded: Pain; Sleep Dysfunction; Speech Disorder
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "MeRT"[tiab]. The summary above synthesizes these.
- Multiple Endoclip Retraction Technique (MERT) in Laparoscopic Burch.
Karadag MA, Demir F, Sonmez G, et al. · JSLS · 2022
- MerP/MerT-mediated mechanism: A different approach to mercury resistance and bioaccumulation by marine bacteria.
Zhang J, Zeng Y, Liu B, et al. · J Hazard Mater · 2020Research Support, Non-U.S. Gov't
- Multiepitope recognition technology promotes the in-depth analysis of antibodyߜdrug conjugates.
Lei Y, Shen Y, Chen F, et al. · Acta Pharm Sin B · 2024
- Defining capabilities in deployed UK military prehospital emergency care.
Thompson M, Jefferson O, James T, et al. · BMJ Mil Health · 2024Editorial
- Role of MerT and MerP from Pseudomonas K-62 plasmid pMR26 in the transport of phenylmercury.
Kiyono M, Uno Y, Omura T, et al. · Biol Pharm Bull · 2000Research Support, Non-U.S. Gov't
- Correction: Macrophage Exclusion after Radiation Therapy (MERT): A First-in-Human Phase I/II Trial using a CXCR4 Inhibitor in Glioblastoma.
Thomas RP, Nagpal S, Iv M, et al. · Clin Cancer Res · 2023Published Erratum
- Overexpression of MerT, the mercuric ion transport protein of transposon Tn501, and genetic selection of mercury hypersensitivity mutations.
Hobman JL, Brown NL · Mol Gen Genet · 1996Research Support, Non-U.S. Gov't
- Direct aperture optimization for FLEC-based MERT and its application in mixed beam radiotherapy.
Alexander A, Soisson E, Renaud MA, et al. · Med Phys · 2012Research Support, Non-U.S. Gov't
- Roles of the Tn21 merT, merP, and merC gene products in mercury resistance and mercury binding.
Hamlett NV, Landale EC, Davis BH, et al. · J Bacteriol · 1992Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- Bacterial detoxification of Hg(II) and organomercurials.
Miller SM · Essays Biochem · 1999Research Support, U.S. Gov't, P.H.S., Review
- Beamlet based direct aperture optimization for MERT using a photon MLC.
Henzen D, Manser P, Frei D, et al. · Med Phys · 2014Research Support, Non-U.S. Gov't
- Forward treatment planning for modulated electron radiotherapy (MERT) employing Monte Carlo methods.
Henzen D, Manser P, Frei D, et al. · Med Phys · 2014Research Support, Non-U.S. Gov't
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.